From: Development of an UPLC-MS/MS method for quantitative analysis of abexinostat levels in rat plasma and application of pharmacokinetics
Analyte
Concentration (ng/mL)
Recovery (%)
Matrix effect (%)
Mean ± SD
RSD (%)
5.00
81.3 ± 11.3
13.8
111.5 ± 13.6
11.4
Abexinostat
40
96.1 ± 2.0
2.1
110.2 ± 2.9
2.6
80
99.6 ± 3.3
3.3
111.8 ± 4.3
4.5